Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

15:24 ET ImaginAb to Present at SNMMI 2019 Annual Meeting

ImaginAb, Inc., a clinical stage immuno-oncology imaging company, today announces that it will attend and present at the upcoming Society of Nuclear...


13:45 ET AbbVie Declares Quarterly Dividend

The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $1.07 per share. The cash dividend is payable August 15,...


13:00 ET Better Together, Parata and TCGRx Offer New Solutions in Pharmacy Automation at McKesson ideaShare 2019

Since merging in December 2018, Parata Systems and TCGRx are poised to display their biggest tradeshow booth to date, one built to showcase several...


11:41 ET OxThera initiiert Verlängerungsteil einer Phase-3-Studie mit Oxabact bei primärer Hyperoxalurie

OxThera AB, ein biopharmazeutisches Unternehmen, das sich auf die Verbesserung des Lebens von Menschen mit primärer Hyperoxalurie konzentriert, gab...


11:39 ET OxThera initie la prolongation d'une étude de phase 3 sur Oxabact pour le traitement de l'hyperoxalurie primaire

OxThera AB, une société biopharmaceutique dédiée à l'amélioration de la vie des patients atteints d'hyperoxalurie primaire, a annoncé aujourd'hui que ...


10:43 ET Pharmacy Technician Certification Board (PTCB) Awards Grants for Medication Safety Projects To Four State Pharmacy Associations

The Pharmacy Technician Certification Board (PTCB) has awarded grants to four state pharmacy associations in Connecticut, Iowa, North Dakota, and...


10:30 ET ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml

ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has received FDA approval of its Prior Approval Supplement for Vancomycin...


10:29 ET Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer

Orion Biotechnology Canada Ltd., today announced new preclinical data evaluating the efficacy of OB-002 (5P12-RANTES) in colorectal cancer. BALB/c...


10:11 ET Prognos and Proclivity Systems Partner to Enable Life Science Brands to Harness Real-world Clinical Signals to Optimize HCP Programmatic Advertising

Prognos, the leader in AI-powered analytics for early tracking and prediction of disease, and Proclivity Systems, the leading digital healthcare data ...


10:02 ET Piramal Pharma Solutions Invests $10 Million USD to Expand its High Potency API Capability in its Riverview Facility in U.S.

Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO), today announced the Grand Opening of a new wing ...


09:00 ET Florence Secures Patent Pioneering New Methods of Remote Monitoring in Clinical Trials

Today Florence announced assignment of U.S. Patent No. 10,319,479 by the United States Patent and Trademark Office for: "Remote Monitoring and...


08:40 ET CSU Institute for Palliative Care, Supportive Care Coalition Announce Total Learning Collaborative™

The Supportive Care Coalition and the California State University Institute for Palliative Care have joined forces in a powerful collaboration...


08:35 ET NCCN and AstraZeneca Seek Opportunities to Improve Outcomes in Advanced Ovarian Cancer

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) is collaborating with AstraZeneca, a global, science-led...


08:20 ET Syntrix Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Clinical Trial of SX-682 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Melanoma

Syntrix Pharmaceuticals today announced that it has dosed the first patient in its Phase 1/2 clinical trial that will combine SX-682 with KEYTRUDA®...


08:03 ET Konica Minolta Healthcare, Novo Nordisk, Philips and Stryker join Emory Healthcare Innovation Hub with Sharecare to improve health care for all

The Emory Healthcare Innovation Hub today announced Konica Minolta Healthcare, Novo Nordisk, Philips and Stryker as its newest strategic partners...


08:00 ET Medicenna Presents New Preclinical Results For its IL-2 Superkine Platform, MDNA109

-Long Acting MDNA109 provides durable tumor control and strong memory response without further treatment when combined with checkpoint inhibitors...


08:00 ET Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, today announced preliminary results of a multi-center ...


08:00 ET CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business

CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that its corporate name has changed from "CollPlant...


08:00 ET Definiens & Targos Innovation: AI-powered multiplex IHC biomarker analytic solutions for precision medicine

Definiens, a leading international Artificial Intelligence (AI)–based biomarker analysis and advanced data mining provider for immuno-oncology...


08:00 ET DURECT Announces $15 Million Registered Direct Offering

DURECT Corporation ("DURECT" or the "Company") (Nasdaq: DRRX) today announced that it has entered into a securities purchase agreement with certain...


08:00 ET Actinium's Portfolio of Antibody Radiation-Conjugates to be Highlighted in Two Oral and Two Poster Presentations at the 2019 Society of Nuclear Medicine and Molecular Imaging Annual Meeting

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced its presence at the upcoming SNMMI or Society of Nuclear Medicine...


07:34 ET OxThera comienza la parte de ampliación de su estudio en Fase 3 de Oxabact en hiperoxaluria primaria

OxThera AB, una compañía biofarmacéutica dedicada a mejorar las vidas de las personas que padecen hiperoxaluria primaria, anunció hoy que ya han...


07:30 ET Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study

Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company, reported today that the U.S. Food and Drug Administration has...


07:30 ET Velan Calls on Progenics Pharmaceuticals' Board to Back Up Recent Claims

Velan Capital, L.P. (together with the other participants in its solicitation, "Velan" or "we"), one of the largest stockholders of Progenics...